EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration

Kaidong Lu iD, Magdalena J Koziol iD

International Journal of Molecular Sciences · 27.12.2025 · 27 (1) · 320

DOI: 10.3390/ijms27010320 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.12.2025. Verfasst von Kaidong Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Sciences, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: Biomarkers, Neurodegenerative Diseases, RNA, Messenger. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 378 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Institute for Brain Research, CIBR’s core grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular RNAs are released from cells and circulate stably in biofluids such as blood, cerebrospinal fluid, saliva, and urine via carriers including extracellular vesicles, RNA-binding proteins and lipoproteins. Because transcriptional and metabolic disturbances—notably mitochondrial dysfunction and oxidative stress—often precede protein aggregation, synaptic loss, and structural change in many brain diseases, exRNAs offer minimally invasive access to early disease biology. Mechanistic studies demonstrate selective RNA packaging and delivery: transferred mRNAs can be translated and miRNAs can modulate targets, indicating exRNAs both report intracellular programs and actively influence recipient cells. Clinical and preclinical data support a dual role for exRNAs as biomarkers and as mediators of pathology. Key technical hurdles—pre-analytical variability, isolation heterogeneity, and uncertain cellular origin—limit reproducibility; recommended solutions include standardized workflows, carrier- and cell type-specific enrichment, multimodal integration with proteomics/metabolomics and neuroimaging, and large, longitudinal validation studies. We synthesize mechanistic and clinical evidence for exRNA utility in early detection, prognosis, and therapeutic targeting and outline a roadmap to translate exRNA findings into robust clinical assays and interventions for neurodegenerative and brain disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersNeurodegenerative DiseasesRNA, MessengerHumansAnimalsExtracellular Vesicles

Stichwörter der Autor:innen

biomarkersblood–brain barrierextracellular RNAextracellular vesiclesmitochondrianeurodegenerationneuroinflammation

Substanzen

BiomarkersRNA, Messenger

Autor:innen und Institutionen

  • College of Biological Sciences, China Agricultural University, Beijing 100193, China.
  • Beijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China.
  • Chinese Institute for Brain Research, Beijing, Beijing 102206, China.

ORCID-Profile: Kaidong Lu, Magdalena J Koziol

Förderung

  • Chinese Institute for Brain Research
  • CIBR’s core grant

Zitieren

APA

Lu, K., & Koziol, M. J. (2025). Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration. International Journal of Molecular Sciences, 27(1), 320. https://doi.org/10.3390/ijms27010320

Vancouver

Lu K, Koziol MJ. Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration. International Journal of Molecular Sciences. 2025;27(1):320. doi:10.3390/ijms27010320

BibTeX
@article{Lu2025,
  author = {Lu, Kaidong and Koziol, Magdalena J},
  title = {Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {320},
  doi = {10.3390/ijms27010320}
}
Kostenlos starten →